A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

被引：10
|
作者：
Liao, Xuemei [1 ]
Ye, Hui [2 ]
Si, Tianmei [1 ]
机构：
[1] Peking Univ, Peking Univ Sixth Hosp, Natl Clin Res Ctr Mental Disorders, NHC Key Lab Mental Hlth,Inst Mental Hlth, Huayuanbeilu 51, Beijing 100191, Peoples R China
[2] Sanofi, Dept Med, Shanghai, Peoples R China
来源：
NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2021年 / 17卷
基金：
国家重点研发计划;
关键词：
antipsychotics; switch; metabolic syndrome; INDUCED WEIGHT-GAIN; DOUBLE-BLIND; LONG-TERM; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; DRUG TREATMENT; ARIPIPRAZOLE; OLANZAPINE; RISK; PREVALENCE;
D O I：
10.2147/NDT.S294521
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Metabolic syndrome (MetS) in patients with schizophrenia occurs 2-3 times more frequently than in the general population. Antipsychotic medication is a primary risk factor for patients with MetS. In particular, the widely used second-generation antipsychotics can affect glucose and lipid metabolism and can induce insulin resistance and other metabolic abnormalities through various receptors. Notably, the metabolic risks of various anti psychotics may differ because of their different pharmacological affinity to MetS-related receptors. Several previous studies have shown that switching from high to low metabolic risk antipsychotics may improve patients' metabolic parameters. The current review aims to discuss the strategies for switching antipsychotic medications and the impact on metabolic abnormalities in patients with schizophrenia.
引用
收藏
页码：453 / 469
页数：17
相关论文
共 50 条
  • [1] Alterations in regional homogeneity in schizophrenia patients comorbid with metabolic syndrome treated with risperidone or clozapine
    Chen, Xinyue
    Wu, Xinyan
    Zhang, Wenjing
    Liao, Kaike
    Yu, Rui
    Lui, Su
    Liu, Nian
    JOURNAL OF PSYCHIATRIC RESEARCH, 2025, 181 : 245 - 252
  • [2] The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone
    Lee, Nam Young
    Kim, Se Hyun
    Jung, Dong Chung
    Kim, Eun Young
    Yu, Han Young
    Sung, Ki Hye
    Kang, Ung Gu
    Ahn, Yong Min
    Kim, Yong Sik
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (05) : 1273 - 1278
  • [3] Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients
    Ventriglio, A.
    Gentile, A.
    Baldessarini, R. J.
    Martone, S.
    Vitrani, G.
    La Marca, A.
    Bellomo, A.
    EUROPEAN PSYCHIATRY, 2014, 29 (07) : 402 - 407
  • [4] Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
    Ijaz, Sharea
    Bolea, Blanca
    Davies, Simon
    Savovic, Jelena
    Richards, Alison
    Sullivan, Sarah
    Moran, Paul
    BMC PSYCHIATRY, 2018, 18
  • [5] Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review)
    Manta, Aspasia
    Georganta, Anastasia
    Roumpou, Afroditi
    Zoumpourlis, Vassilis
    Spandidos, Demetrios A.
    Rizos, Emmanouil
    Peppa, Melpomeni
    MOLECULAR MEDICINE REPORTS, 2025, 31 (05)
  • [6] Prevalence of Metabolic Syndrome, Characteristics of Metabolic Syndrome and Relationship with the Antipsychotics Used in Schizophrenia
    Kaya, Mehmet Cemal
    Virit, Osman
    Altindag, Abdurrahman
    Selek, Salih
    Bulbul, Feridun
    Bulut, Mahmut
    Savas, Haluk A.
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2009, 46 (01): : 13 - 18
  • [7] The evaluation on metabolic syndrome and nutrition in patients with schizophrenia
    Sanlier, Nevin
    Ayyildiz, Feride
    Urhan, Murat
    Toka, Onur
    PROGRESS IN NUTRITION, 2019, 21 : 210 - 219
  • [8] Prevalence of metabolic syndrome in patients with schizophrenia in India
    Grover, Sandeep
    Aggarwal, Munish
    Dutt, Alakananda
    Chakrabarti, Subho
    Avasthi, Ajit
    Kulhara, Parmanand
    Somaiya, Mansi
    Malhotra, Nidhi
    Chauhan, Nidhi
    PSYCHIATRY RESEARCH, 2012, 200 (2-3) : 1035 - 1037
  • [9] Metabolic syndrome in people with schizophrenia: a review
    De Hert, Marc
    Schreurs, Vincent
    Vancampfort, Davy
    Van Winkel, Ruud
    WORLD PSYCHIATRY, 2009, 8 (01) : 15 - 22
  • [10] Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
    Sneller, Marius H.
    de Boer, Nini
    Everaars, Sophie
    Schuurmans, Max
    Guloksuz, Sinan
    Cahn, Wiepke
    Luykx, Jurjen J.
    FRONTIERS IN PSYCHIATRY, 2021, 12
12345